Free
E-newsletter
Subscribe to Housecall
Our weekly general interest
e-newsletter keeps you up to date
on a wide variety of health topics.
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Bortezomib (Intravenous Route, Subcutaneous Route)
Drug Information provided by: MicromedexUS Brand Names
|
Description
Bortezomib injection is given together with melphalan and prednisone to treat multiple myeloma (blood plasma cell cancer) in patients with or without a prior history of treatment, and mantle cell lymphoma in patients who have received at least one treatment and did not worked well.
Bortezomib interferes with the growth of cancer cells, which are then eventually destroyed by the body. Since the growth of normal body cells may also be affected by bortezomib, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, such as a skin rash, may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.
This medicine is to be administered only by or under the supervision of your doctor.
This product is available in the following dosage forms:
- Powder for Solution
Find Mayo Clinic on